Aristo Bio-Tech & Lifescience Ltd
Incorporated in 2005, Aristo Bio-Tech and Lifescience Ltd manufactures and supplies pesticides and agrochemicals[1]
- Market Cap ₹ 68.0 Cr.
- Current Price ₹ 99.8
- High / Low ₹ 140 / 74.3
- Stock P/E 9.47
- Book Value ₹ 65.4
- Dividend Yield 0.50 %
- ROCE 19.5 %
- ROE 17.6 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 46.1% CAGR over last 5 years
Cons
- Company has a low return on equity of 13.9% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Part of Nifty SME Emerge
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 57 | 159 | 271 | 202 | 201 | 167 | 166 | 218 | 245 | 318 | 364 | |
| 56 | 157 | 263 | 195 | 197 | 163 | 160 | 209 | 236 | 309 | 348 | |
| Operating Profit | 1 | 3 | 7 | 7 | 5 | 4 | 5 | 9 | 8 | 9 | 16 |
| OPM % | 2% | 2% | 3% | 3% | 2% | 3% | 3% | 4% | 3% | 3% | 4% |
| 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Interest | 0 | 1 | 2 | 2 | 3 | 2 | 2 | 3 | 2 | 2 | 4 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 3 |
| Profit before tax | 1 | 3 | 6 | 4 | 1 | 2 | 2 | 5 | 5 | 5 | 10 |
| Tax % | 33% | 31% | 34% | 31% | 28% | 28% | 28% | 25% | 28% | 26% | 26% |
| 0 | 2 | 4 | 3 | 1 | 1 | 1 | 4 | 4 | 4 | 7 | |
| EPS in Rs | 4.00 | 18.52 | 37.44 | 5.67 | 2.02 | 2.16 | 2.14 | 5.23 | 5.73 | 5.96 | 10.55 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 5% | 7% | 8% | 6% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 17% |
| 3 Years: | 19% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 33% |
| 5 Years: | 46% |
| 3 Years: | 26% |
| TTM: | 79% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 20% |
| 1 Year: | -22% |
| Return on Equity | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 14% |
| 3 Years: | 14% |
| Last Year: | 18% |
Balance Sheet
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 5 | 5 | 5 | 5 | 7 | 7 | 7 | 7 |
| Reserves | 2 | 4 | 7 | 6 | 7 | 8 | 10 | 23 | 27 | 31 | 38 |
| 5 | 10 | 20 | 14 | 20 | 22 | 25 | 22 | 21 | 22 | 35 | |
| 20 | 72 | 60 | 65 | 56 | 46 | 37 | 47 | 73 | 81 | 75 | |
| Total Liabilities | 27 | 87 | 89 | 91 | 88 | 81 | 77 | 100 | 127 | 141 | 155 |
| 2 | 2 | 8 | 8 | 8 | 12 | 14 | 16 | 22 | 24 | 24 | |
| CWIP | 0 | 0 | 0 | 1 | 3 | 0 | 0 | 1 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 25 | 85 | 81 | 81 | 77 | 69 | 63 | 83 | 106 | 117 | 131 | |
| Total Assets | 27 | 87 | 89 | 91 | 88 | 81 | 77 | 100 | 127 | 141 | 155 |
Cash Flows
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -4 | 1 | 8 | 1 | 2 | 7 | -3 | 8 | 10 | 8 | ||
| 0 | -5 | -2 | -2 | -2 | -3 | -4 | -7 | -5 | -3 | ||
| 4 | 4 | -6 | 1 | -1 | -3 | 8 | -2 | -4 | -4 | ||
| Net Cash Flow | 0 | -0 | -0 | 0 | -0 | 0 | 1 | -1 | 0 | 2 | |
| Free Cash Flow | -4 | 0 | 6 | -1 | 0 | 4 | -7 | 1 | 5 | 5 | |
| CFO/OP | -123% | 38% | 138% | 40% | 60% | 134% | -17% | 106% | 123% | 69% |
Ratios
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 92 | 121 | 65 | 77 | 88 | 72 | 73 | 75 | 86 | 65 | 55 |
| Inventory Days | 66 | 67 | 42 | 65 | 47 | 78 | 60 | 57 | 65 | 59 | 70 |
| Days Payable | 142 | 177 | 85 | 124 | 74 | 93 | 87 | 85 | 112 | 97 | 78 |
| Cash Conversion Cycle | 16 | 11 | 23 | 18 | 61 | 56 | 46 | 48 | 38 | 26 | 46 |
| Working Capital Days | 3 | 14 | 14 | 15 | 20 | 28 | 25 | 37 | 31 | 22 | 25 |
| ROCE % | 31% | 34% | 24% | 14% | 11% | 12% | 16% | 13% | 12% | 20% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| CIB&RC Product Registrations number |
|
||
| Domestic Sales Share of Revenue % |
|||
| Domestic States Supplied number |
|||
| Export Countries Served number |
|||
| Export Sales Share of Revenue % |
|||
| Job Work Income Share of Revenue % |
|||
| Permanent Employees number |
|||
Extracted by Screener AI
Documents
Announcements
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
7 July 2026 - Submitted Regulation 74(5) certificate for quarter ended June 30, 2026.
-
Dividend
30 May 2026 - Board approved FY26 audited results, recommended Rs0.60 final dividend, and reported unmodified audit opinion.
-
Outcome of Board Meeting
30 May 2026 - Board approved FY26 audited results, unmodified audit opinion, and recommended Rs0.60 final dividend per share.
-
Structural Digital Database
28 May 2026 - Submitted SDD compliance certificate for FY2026 under SEBI PIT Regulations.
-
Disclosure under SEBI Takeover Regulations
25 May 2026 - Narendra Singh Barhat has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, …
Business Overview:[1]
ABTL, an ISO 9001:2008 certified company, manufactures, formulates, supplies, and packages various pesticides, including insecticides, herbicides, fungicides, plant growth regulators, and other agrochemicals. It currently has 257 products registered with CIB&RC for manufacturing and sales, serving both domestic and international customers.